Ignite Creation Date:
2024-05-06 @ 3:34 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04670913
Status:
UNKNOWN
Last Update Posted:
2021-06-29
First Post:
2020-11-26
Brief Title:
Camrelizumab Plus Apatinib for Advanced Non-Squamous NSCLC Previously Treated With First-Line Immunotherapy
Sponsor:
Junling Li
Organization:
Peking Union Medical College
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-28
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-06
Completion Date Type:
ESTIMATED
First Submit Date:
2020-11-26
First Submit QC Date:
December 14 2020
Study First Post Date:
2020-12-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-27
Last Update Post Date:
2021-06-29
Last Update Post Date Type:
ACTUAL